Rafael holdings reports third quarter fiscal 2023 financial results and provides business update

Since the end of the third quarter, we made an initial $2.1 million investment in cyclo therapeutics, inc. (nasdaq: cyth) and have an agreement to increase our investment by $5 million since the end of the third quarter, we made an initial $2.1 million investment in cyclo therapeutics, inc. (nasdaq: cyth) and have an agreement to increase our investment by $5 million
RFL Ratings Summary
RFL Quant Ranking